JP2014504865A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014504865A5 JP2014504865A5 JP2013547842A JP2013547842A JP2014504865A5 JP 2014504865 A5 JP2014504865 A5 JP 2014504865A5 JP 2013547842 A JP2013547842 A JP 2013547842A JP 2013547842 A JP2013547842 A JP 2013547842A JP 2014504865 A5 JP2014504865 A5 JP 2014504865A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- reference nucleic
- binding
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11000117.9 | 2011-01-10 | ||
| EP11000117 | 2011-01-10 | ||
| PCT/EP2011/002068 WO2011131371A1 (en) | 2010-04-21 | 2011-04-21 | Lipid binding nucleic acids |
| EPPCT/EP2011/002068 | 2011-04-21 | ||
| EP11008467 | 2011-10-21 | ||
| EP11008467.0 | 2011-10-21 | ||
| PCT/EP2012/000089 WO2012095303A1 (en) | 2011-01-10 | 2012-01-10 | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017075557A Division JP2017148055A (ja) | 2011-01-10 | 2017-04-05 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014504865A JP2014504865A (ja) | 2014-02-27 |
| JP2014504865A5 true JP2014504865A5 (https=) | 2015-03-05 |
Family
ID=45464586
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013547842A Pending JP2014504865A (ja) | 2011-01-10 | 2012-01-10 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
| JP2017075557A Pending JP2017148055A (ja) | 2011-01-10 | 2017-04-05 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017075557A Pending JP2017148055A (ja) | 2011-01-10 | 2017-04-05 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9976145B2 (https=) |
| EP (1) | EP2663640B1 (https=) |
| JP (2) | JP2014504865A (https=) |
| KR (2) | KR102080142B1 (https=) |
| CN (1) | CN103339258A (https=) |
| AU (1) | AU2012206750A1 (https=) |
| CA (1) | CA2824073A1 (https=) |
| WO (1) | WO2012095303A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014533098A (ja) * | 2011-10-21 | 2014-12-11 | ノクソン・ファルマ・アクチエンゲゼルシャフト | グルカゴン結合核酸 |
| KR102034203B1 (ko) * | 2012-01-10 | 2019-10-18 | 아프타리온 바이오테크 아게 | 새로운 C5a 결합 핵산 |
| BR112014016939A2 (pt) * | 2012-01-10 | 2019-09-24 | Noxxon Pharma Ag | ácidos nucleicos que se ligam especificamente a cgrp |
| US11172873B2 (en) | 2018-05-17 | 2021-11-16 | The Procter & Gamble Company | Systems and methods for hair analysis |
| WO2019222340A1 (en) | 2018-05-17 | 2019-11-21 | The Procter & Gamble Company | Systems and methods for hair coverage analysis |
| CN112771164B (zh) | 2018-06-29 | 2026-03-27 | 宝洁公司 | 用于个人护理应用的适配体 |
| CA3134968A1 (en) | 2019-04-16 | 2020-10-22 | Juan Esteban Velasquez | Aptamers for odor control applications |
| US12039732B2 (en) | 2021-04-14 | 2024-07-16 | The Procter & Gamble Company | Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications |
| EP4306640A1 (en) | 2022-06-21 | 2024-01-17 | TME Pharma AG | Method for treating a tumor in a subject |
| KR20250025627A (ko) | 2022-06-21 | 2025-02-24 | 티엠이 파마 아게 | 대상체의 종양을 치료하는 방법 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2259800T3 (es) | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| DE59708838D1 (de) | 1996-08-30 | 2003-01-09 | Jens Peter Fuerste | Spiegelselektion und spiegelevolution von nucleinsäuren |
| US6395029B1 (en) | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| EP1264603B8 (en) * | 2001-06-10 | 2010-03-03 | Noxxon Pharma AG | Use of L-polynucleotides for in vivo imaging |
| EP1306382A1 (de) | 2001-10-26 | 2003-05-02 | Noxxon Pharma AG | Modifizierte L-Nukleinsäure |
| ATE469164T1 (de) | 2001-10-26 | 2010-06-15 | Noxxon Pharma Ag | Modifizierte l-nukleinsäure |
| WO2003070823A2 (en) | 2002-02-20 | 2003-08-28 | The General Hospital Corporation | Conjugates comprising a biodegradable polymer and uses therefor |
| NZ542687A (en) | 2003-04-13 | 2010-02-26 | Enzon Pharmaceuticals Inc | Polymeric oligonucleotide prodrugs |
| GB0314472D0 (en) | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
| OA13282A (en) | 2003-11-10 | 2007-01-31 | Noxxon Pharma Ag | Nucleic acids specifically binding bioactive ghrelin. |
| CA2555467C (en) | 2004-02-09 | 2012-10-09 | Noxxon Pharma Ag | Process for the production of conjugates from polysaccharides and polynucleotides |
| CA2940803A1 (en) | 2004-03-23 | 2005-10-27 | Ascendis Pharma Gmbh | Prodrug linker |
| US7579450B2 (en) | 2004-04-26 | 2009-08-25 | Archemix Corp. | Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics |
| JP5107716B2 (ja) | 2004-11-05 | 2012-12-26 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | 分子治療用生分解性リンカー |
| US20090075342A1 (en) | 2005-04-26 | 2009-03-19 | Sharon Cload | Metabolic profile directed aptamer medicinal chemistry |
| US20120101267A1 (en) | 2005-10-07 | 2012-04-26 | Alison Velyian Todd | Multicomponent nucleic acid enzymes with cleavage, ligase or other activity and methods for their use |
| JP5665272B2 (ja) | 2005-10-07 | 2015-02-04 | スピーデクス ピーティーワイ リミテッド | 多成分核酸酵素およびそれらの使用方法 |
| MX2009002859A (es) | 2006-09-15 | 2009-03-30 | Enzon Pharmaceuticals Inc | Enlazadores biodegradables a base de ester impedido para suministro de oligonucleotidos. |
| US8962238B2 (en) | 2007-04-05 | 2015-02-24 | SpeedDx Pty Ltd | Nucleic acid enzymes and complexes and methods for their use |
| WO2010014572A2 (en) * | 2008-07-28 | 2010-02-04 | Idera Pharmaceuticals, Inc. | Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| EP2561079A1 (en) | 2010-04-21 | 2013-02-27 | Noxxon Pharma AG | Lipid binding nucleic acids |
-
2012
- 2012-01-10 US US13/978,804 patent/US9976145B2/en active Active
- 2012-01-10 CA CA2824073A patent/CA2824073A1/en not_active Abandoned
- 2012-01-10 KR KR1020197016125A patent/KR102080142B1/ko active Active
- 2012-01-10 KR KR1020137017897A patent/KR20140026357A/ko not_active Ceased
- 2012-01-10 CN CN201280007720XA patent/CN103339258A/zh active Pending
- 2012-01-10 AU AU2012206750A patent/AU2012206750A1/en not_active Abandoned
- 2012-01-10 EP EP12700093.3A patent/EP2663640B1/en active Active
- 2012-01-10 WO PCT/EP2012/000089 patent/WO2012095303A1/en not_active Ceased
- 2012-01-10 JP JP2013547842A patent/JP2014504865A/ja active Pending
-
2017
- 2017-04-05 JP JP2017075557A patent/JP2017148055A/ja active Pending
-
2018
- 2018-05-21 US US15/985,626 patent/US20190367921A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014504865A5 (https=) | ||
| JP2017536119A5 (https=) | ||
| JP2020532961A5 (https=) | ||
| Pu et al. | Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment | |
| JP2013511990A5 (https=) | ||
| JP2013516190A5 (https=) | ||
| JP2014511686A5 (https=) | ||
| Aljabr et al. | Investigating the influence of ribavirin on human respiratory syncytial virus RNA synthesis by using a high-resolution transcriptome sequencing approach | |
| JP2014513954A5 (https=) | ||
| JP2014504857A5 (https=) | ||
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| JP2016530294A5 (https=) | ||
| JP2015517806A5 (https=) | ||
| JP2008283975A5 (https=) | ||
| JP2017070307A5 (https=) | ||
| WO2007090071A3 (en) | 6-modified bicyclic nucleic acid analogs | |
| JP2017079759A5 (https=) | ||
| JP2012050438A5 (https=) | ||
| JP2013535212A5 (https=) | ||
| JP2013524792A5 (https=) | ||
| JP2009017881A5 (https=) | ||
| JP2012136542A5 (https=) | ||
| JP2009543567A5 (https=) | ||
| JP2015128433A5 (https=) | ||
| JP2017523781A5 (https=) |